蛋白質合成研究綜述：2025

2024 年全球工業酵素市場價值為 79 億美元，預計從 2024 年到 2029 年將以 6.5% 的複合年成長率成長，到 2029 年底達到 108 億美元。

全球寡核苷酸市場預計將從2024年的82億美元和2025年的91億美元增加到2030年底的157億美元。 2025年至2030年的複合年成長率預計為11.5%。

預計到 2030 年底，全球蛋白質表現市場規模將達到 79 億美元，高於 2024 年的 43 億美元和 2025 年的 47 億美元，2025 年至 2030 年的複合年成長率為 10.9%。

蛋白質合成對所有生物體都至關重要，它使細胞能夠產生生存和功能所需的蛋白質。這是一個基本的生物學過程，它在細胞內建構蛋白質，對所有細胞功能都不可或缺。蛋白質合成的主要成分包括去氧核糖核酸（DNA）、核糖核酸（RNA）、核醣體和胺基酸。

慢性病盛行率的上升推動了對蛋白質療法的需求不斷成長，這是推動蛋白質合成市場發展的主要因素。無細胞系統和表現載體的進步提高了效率和生產力，也促進了蛋白質合成市場的擴張。無細胞系統和高通量技術的進步，以及對個人化醫療的關注，也是蛋白質合成市場成長的重要因素。另一方面，高昂的生產成本和複雜的技術也對該市場的成長構成了一定的限制。

本研究綜述重點摘錄了BCC Research關於蛋白質合成（包括工業酵素、寡核苷酸和蛋白質表現）的2025年報告。內容涵蓋市場概況、市場影響因素和機會、法律制度、新興技術和發展趨勢、市場規模趨勢和預測，以及按不同細分市場和地區進行的詳細分析。

目錄

第1章：序言

第2章：工業酵素的全球市場（BIO030M）

• 市場展望
• 調查範圍
• 市場概況
• 市場概覽
• 工業酵素的歷史背景
• 酵素命名法
• 酶的分類
• 基於化學反應催化作用的分類
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興科技與發展
• 酶工程的進展
• 人工酵素
• 市場分析：按類型
• 碳水化合物消化酶
• 蛋白酶
• 聚合酵素和核酸酶
• 植酸酶
• 脂肪酶
• 其他
• 市場分析：按來源
• 微生物
• 植物
• 動物
• 市場分析：按地區分類
• 市場規模及預測
• 北美洲
• 亞太地區
• 歐洲
• 其他地區
• 工業酵素市場的永續性
• BCC的結語

第3章 蛋白質表現：全球市場（BIO165B）

• 市場展望
• 調查範圍
• 市場概況
• 市場成長要素
• 新興技術
• 細分市場分析
• 區域分析
• 結論
• 市場概覽
• 蛋白質表現工作流程
• 細胞類型選擇
• 質體選擇
• 細胞表現系統的選擇
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興科技與發展
• CRISPR/Cas9基因編輯
• 合成生物學
• AI在蛋白質表現中的整合
• 市場區隔
• 市場區隔：依系統類型
• 重點
• 原核表現系統
• 哺乳動物細胞表現系統
• 酵母表現系統
• 昆蟲細胞表現系統
• 無細胞表現系統
• 基於藻類的表達系統
• 市場區隔：依產品類型
• 重點
• 試劑
• 表達向量
• 勝任細胞
• 裝置
• 服務
• 市場區隔：按地區
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 蛋白質表現市場的永續性
• 了解ESG數據
• ESG績效分析
• 環境績效
• 社會表現
• 管治績效
• BCC的結語

第4章 寡核苷酸：全球市場（BIO220C）

• 市場展望
• 調查範圍
• 市場概況
• 市場動態與成長要素
• 新興技術
• 細分市場分析
• 區域分析
• 結論
• 市場概覽
• 寡核苷酸的類型
• 寡核苷酸的作用機制
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興科技與發展
• 重點
• 酶促寡核苷酸合成
• RNAi遞送系統的進展
• 用於無創健康監測的循環 miRNA 診斷
• 市場區隔
• 重點
• 寡核苷酸藥物
• 合成寡糖
• 設備和試劑
• 服務
• 市場區隔：按地區
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 永續性：ESG觀點
• ESG風險評估
• 結論

第5章：細胞與基因治療工具及試劑：全球市場（BIO208D）

• 市場展望
• 調查範圍
• 市場概況
• 概述
• 當前市場狀況
• 細分市場分析
• 區域市場分析
• 新興技術
• 結論
• 市場概覽
• 細胞和基因治療概述
• 細胞療法
• 基因治療
• 市場動態
• 市場促進因素
• 增加對CGT研究的投資
• 市場限制因素
• 市場機遇
• 新興科技與發展
• 重點
• 閉迴路自動化系統
• 市場區隔分析
• 重點
• 免疫檢測
• 生物反應器
• 白血球分離療法
• GMP抗體
• 多重免疫檢測
• 向量
• 細胞分離
• 冷凍保存
• 細胞增殖
• 媒體
• GMP蛋白
• 符合GMP規範的小分子化合物
• CRS監測
• 市場分析：按地區分類
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 從永續性到ESG觀點
• 關於永續性的趨勢和企業舉措
• 環境因素
• 社會因素
• 管治因素
• 社會與管治計劃
• 結論

第6章：生物標記：各種技術與全球市場（BIO061G）

• 市場展望
• 調查範圍
• 市場概況
• 市場概覽
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興科技與發展
• 基因組學
• 市場區隔分析
• 市場分析：依產品類型
• 消耗品
• 裝置
• 服務
• 軟體
• 市場分析：按技術分類
• 蛋白質體學
• 基因組學
• 影像
• 生物資訊學
• 代謝體學
• 胜肽合成市場：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 生物標記市場的永續性
• ESG風險與評級：理解數據
• 結論

第7章附錄

The global market for enzymes in industrial applications was valued at $7.9 billion in 2024 and is expected to reach $10.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.5% from 2024 through 2029.

The global oligonucleotides market was valued at $8.2 billion in 2024. It’s expected to grow from $9.1 billion in 2025 to reach $15.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2030.

The global market for protein expression was valued at $4.3 billion in 2024. It’s expected to grow from $4.7 billion in 2025 to reach $7.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.9% from 2025 to 2030.

Report Scope

Protein synthesis is vital for all living organisms, enabling cells to produce the proteins they need to survive and function. It is a basic biological process that builds proteins in cells, which is essential for every cellular function. The key components of protein synthesis are deoxyribonucleic acid (DNA), ribonucleic acid (RNA), ribosomes, and amino acids.

The growing demand for protein therapeutics due to the increase in the prevalence of chronic diseases is a major factor driving this market. Advances in cell-free systems and improved expression vectors, which enhance efficiency and productivity, also help to boost the protein synthesis market. The developments toward cell-free systems, high-throughput technologies, and a focus on personalized medicine also act as key factors for the growth of the protein synthesis market. The high production costs and complex techniques also affect this market's growth.

The market includes major companies such as Novartis, Jazz Pharmaceuticals, Amgen Inc., Novonesis, DSM- Firmenich, Thermo Fisher Scientific Inc, Lonza, Merck KGaA, Agilent Technologies, Cytiva, Illumina Inc, Bio Rad Laboratories Inc, Agilent Technologies Inc, Pfizer Inc., Genentech, USA Inc., and Eli Lilly, which mainly focus on protein therapeutics. The companies focusing on protein synthesis research and development include GenScript ProBio, Aldevron, Creative Biogene, and Tierra Biosciences Inc.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2025 Research Review of protein synthesis provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2025:

• BIO030M Global Markets for Enzymes in Industrial Applications
• BIO220C Oligonucleotides: Global Markets
• BIO165B Protein Expression: Global Markets
• BIO208D Cell and Gene Therapy Tools and Reagents: Global Markets
• BIO061G Biomarkers: Technologies and Global Markets

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Global Markets for Enzymes in Industrial Applications(BIO030M)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Historical Background of Industrial Enzymes
• Enzyme Nomenclature
• Enzyme Classification
• Classification Based on Chemical Reaction Catalysis
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• Advances in Enzyme Engineering
• Artificial Enzymes
• Market Analysis by Type
• Carbohydrase
• Protease
• Polymerase and Nuclease
• Phytase
• Lipase
• Others
• Market Analysis by Source
• Microorganisms
• Plants
• Animals
• Market Analysis by Region
• Market Size and Forecast
• North America
• Asia-Pacific
• Europe
• Rest of the World
• Sustainability in the Industrial Enzymes Market
• Concluding Remarks from BCC

Chapter 3 Protein Expression: Global Markets (BIO165B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Protein Expression Workflow
• Choice of Cell Type
• Choice of Plasmid
• Choice of Cell Expression System
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• CRISPR/Cas9 Genome Editing
• Synthetic Biology
• AI Integration in Protein Expression
• Market Breakdown
• Market Breakdown by System Type
• Key Takeaways
• Prokaryotic Expression Systems
• Mammalian Cell Expression Systems
• Yeast Expression Systems
• Insect Cell Expression Systems
• Cell-Free Expression Systems
• Algal-based Expression Systems
• Market Breakdown by Product Type
• Key Takeaways
• Reagents
• Expression Vectors
• Competent Cells
• Instruments
• Services
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Protein Expression Market
• Understanding ESG Data
• ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 4 Oligonucleotides: Global Markets (BIO220C)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Types of Oligonucleotides
• Mechanisms of Action of Oligonucleotides
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• Key Takeaways
• Enzymatic Oligonucleotide Synthesis
• Advances in RNAi Delivery Systems
• Circulating miRNA Diagnostics for Noninvasive Health Monitoring
• Market Breakdown
• Key Takeaways
• Oligonucleotide Drugs
• Synthesized Oligos
• Equipment and Reagents
• Services
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability An ESG Perspective
• ESG Risk Ratings
• Conclusion

Chapter 5 Cell and Gene Therapy Tools and Reagents: Global Markets(BIO208D)

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Market Insights
• Emerging Technologies
• Conclusion
• Market Overview
• Cell and Gene Therapy Overview
• Cell Therapy
• Gene Therapy
• Market Dynamics
• Market Drivers
• Increasing Investments in CGT Research
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• Key Takeaways
• Closed and Automated Systems
• Market Breakdown Analysis
• Key Takeaways
• Immunoassays
• Bioreactors
• Leukapheresis
• GMP Antibodies
• Multiplex Immunoassays
• Vectors
• Cell Separation
• Cryopreservation
• Cell Expansion
• Media
• GMP Proteins
• GMP Small Molecules
• CRS Monitoring
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability to ESG Perspective
• Sustainability Trends and Company Initiatives
• Environmental Factors
• Social Factors
• Governance Factors
• Social and Governance Initiatives
• Concluding Remarks

Chapter 6 Biomarkers: Technologies and Global Markets (BIO061G)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraint
• Market Opportunities
• Emerging Technologies and Development
• Genomics
• Market Breakdown Analysis
• Market Analysis by Product Type
• Consumables
• Instruments
• Services
• Software
• Market Analysis by Technology
• Proteomics
• Genomics
• Imaging
• Bioinformatics
• Metabolomics
• Market for Peptide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Biomarker Market
• ESG Risks and Ratings: Understanding the Data
• BCC Research Viewpoint

Chapter 7 Appendix

• Research Methodology
• Analyst's Credentials

List of Tables

• Table 1 : Global Market for Enzymes in Industrial Applications, by Region, Through 2029
• Table 2 : Historical Events Related to Enzymes, 1830s-Present
• Table 3 : Global Market for Enzymes in Industrial Applications, by Type, Through 2029
• Table 4 : Industrial Applications of Carbohydrase Enzymes
• Table 5 : Major Industrial Applications for Cysteine Protease
• Table 6 : Global Market for Enzymes in Industrial Applications, by Source, Through 2029
• Table 7 : Industrial Applications of Microbial Enzymes
• Table 8 : Global Market for Enzymes in Industrial Applications, by Region, Through 2029
• Table 9 : Primary ESG Goals of Industrial Enzyme Companies
• Table 10 : Global Market for Protein Expression, by Region, Through 2030
• Table 11 : Comparison of Protein Expression Systems and Their Respective Advantagesand Disadvantages
• Table 12 : Advantages, Challenges and Most Common Applications of ProteinExpression Systems
• Table 13 : Global Market for Protein Expression, by Type, Through 2030
• Table 14 : Global Market for Protein Expression, by Product, Through 2030
• Table 15 : Characteristics of Commonly Used Expression Hosts
• Table 16 : Select Protein Expression Services
• Table 17 : Global Market for Protein Expression, by Region, Through 2030
• Table 18 : European-based Companies' R&D Expenditures and Comparison of Their Net Sales, 2023
• Table 19 : Key Focus Areas in ESG Metrics
• Table 20 : ESG Rankings for Major Protein Expression Companies, 2025*
• Table 21 : ESG: Environmental Overview
• Table 22 : ESG: Social Overview
• Table 23 : ESG: Governance Overview
• Table 24 : Global Market for Oligonucleotides, by Region, Through 2030
• Table 25 : FDA-Approved ASOs
• Table 26 : RNAi-Approved Drug List
• Table 27 : Global Market for Oligonucleotides, by Product Type, Through 2030
• Table 28 : Global Market for Oligonucleotides, by Region, Through 2030
• Table 29 : Key Focus Areas in ESG Metrics
• Table 30 : ESG Risk Rankings for Oligonucleotide Companies, 2025
• Table 31 : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
• Table 32 : Global Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
• Table 33 : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
• Table 34 : ESG: Environmental Overview
• Table 35 : Key Social and Governance Issues in the Global Market for Cell and Gene Therapy Tools and Reagents
• Table 36 : Global Market for Biomarkers, by Region, Through 2029
• Table 37 : Global Market for Biomarkers, Through 2029
• Table 38 : Global Market for Biomarkers, by Product Type, Through 2029
• Table 39 : Global Market for Biomarkers, by Technology, Through 2029
• Table 40 : Global Market for Peptide Synthesis, by Region, Through 2028
• Table 41 : ESG Rankings for Major Biomarker Companies, 2024*

List of Figures

• Figure 1 : Global Market Shares of Enzymes in Industrial Applications, by Region, 2023
• Figure 2 : Enzyme Engineering Methods
• Figure 3 : Global Market Shares of Enzymes in Industrial Applications, by Type, 2023
• Figure 4 : Industrial Applications of Lipase Enzymes
• Figure 5 : Global Market Shares of Enzymes in Industrial Applications, by Source, 2023
• Figure 6 : Advantages of Microbial Enzymes for Industrial Applications
• Figure 7 : Global Market Shares of Enzymes in Industrial Applications, by Region, 2023
• Figure 8 : Global Market for Enzymes in Industrial Applications, by Region, 2021-2029
• Figure 9 : Sustainability Benefits of Industrial Enzymes
• Figure 10 : Global Market Shares of Protein Expression, by Region, 2024
• Figure 11 : Protein Expression Workflow
• Figure 12 : Global Market Shares of Protein Expression, by Type, 2024
• Figure 13 : Global Market Shares of Protein Expression, by Product, 2024
• Figure 14 : Global Market Shares of Protein Expression, by Region, 2024
• Figure 15 : How a Strong ESG Proposition Benefits Businesses
• Figure 16 : Global Market Shares for Oligonucleotides, by Region, 2024
• Figure 17 : Global Market Shares for Oligonucleotides, by Product Type, 2024
• Figure 18 : Global Market Shares for Oligonucleotides, by Region, 2024
• Figure 19 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Region, 2024
• Figure 20 : Market Investments for Cell and Gene Therapy, by Year, 2019-2024
• Figure 21 : Market Investments for Cell and Gene Therapy, by Deal Type, H1 2025
• Figure 22 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Product Type, 2024
• Figure 23 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Region, 2024
• Figure 24 : Global Market Shares for Biomarkers, by Product Type, 2023
• Figure 25 : Global Market Shares for Biomarkers, by Technology, 2023